IL47299A0 - Cephalosporin compounds their preparation and pharmaceutical compositions containing them - Google Patents
Cephalosporin compounds their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL47299A0 IL47299A0 IL47299A IL4729975A IL47299A0 IL 47299 A0 IL47299 A0 IL 47299A0 IL 47299 A IL47299 A IL 47299A IL 4729975 A IL4729975 A IL 4729975A IL 47299 A0 IL47299 A0 IL 47299A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- cephalosporin compounds
- cephalosporin
- Prior art date
Links
- 229930186147 Cephalosporin Natural products 0.000 title 1
- -1 Cephalosporin compounds Chemical class 0.000 title 1
- 229940124587 cephalosporin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH853774A CH609989A5 (en) | 1974-06-21 | 1974-06-21 | Process for the preparation of acyl derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL47299A0 true IL47299A0 (en) | 1976-10-31 |
| IL47299A IL47299A (en) | 1979-01-31 |
Family
ID=4341690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL47299A IL47299A (en) | 1974-06-21 | 1975-05-14 | 3-thiomethyl-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them |
Country Status (25)
| Country | Link |
|---|---|
| JP (1) | JPS625917B2 (en) |
| AT (1) | AT337897B (en) |
| AU (1) | AU498387B2 (en) |
| BE (1) | BE830455A (en) |
| BR (1) | BR7503782A (en) |
| CA (1) | CA1111021A (en) |
| CH (1) | CH609989A5 (en) |
| CU (1) | CU34293A (en) |
| DD (1) | DD121113A5 (en) |
| DE (1) | DE2527291A1 (en) |
| DK (2) | DK153155C (en) |
| FI (1) | FI751815A7 (en) |
| FR (1) | FR2275215A1 (en) |
| GB (1) | GB1471804A (en) |
| HU (1) | HU170576B (en) |
| IE (1) | IE41888B1 (en) |
| IL (1) | IL47299A (en) |
| LU (1) | LU72771A1 (en) |
| NL (1) | NL180665C (en) |
| NO (1) | NO752202L (en) |
| NZ (1) | NZ177508A (en) |
| PH (1) | PH13030A (en) |
| SE (1) | SE431755B (en) |
| SU (2) | SU635873A3 (en) |
| ZA (1) | ZA753086B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7805715A (en) * | 1977-06-03 | 1978-12-05 | Hoffmann La Roche | METHOD FOR PREPARING ACYL DERIVATIVES. |
| JPS5419990A (en) * | 1977-07-14 | 1979-02-15 | Shionogi & Co Ltd | Dihydrotriazinylthioxacephalosporin |
| MC1259A1 (en) * | 1978-05-30 | 1980-01-14 | Hoffmann La Roche | ACYL DERIVATIVES |
| FR2474030A1 (en) * | 1980-01-17 | 1981-07-24 | Rhone Poulenc Ind | 2-Mercapto-1,2,4-triazine, 1,3,4-triazole or tetrazole derivs. - useful as intermediates for antibacterial cephalosporin(s) |
| FR2494278A1 (en) * | 1980-11-20 | 1982-05-21 | Rhone Poulenc Ind | NEW DERIVATIVES OF CEPHALOSPORIN, THEIR PREPARATIONS AND THE MEDICINAL PRODUCTS CONTAINING THEM |
| AU2002310863A1 (en) * | 2001-04-19 | 2002-11-05 | Bioferma Murcia, S.A. | Enzymatic process for preparing cephalosporanic acid derivatives using alpha-ketoacid derivatives |
| AU2009221328B2 (en) | 2008-03-05 | 2014-02-27 | Merck Patent Gmbh | Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3868369A (en) * | 1972-11-14 | 1975-02-25 | Smithkline Corp | 3-heterocyclicthiomethylcephalosporins |
-
1974
- 1974-06-21 CH CH853774A patent/CH609989A5/en not_active IP Right Cessation
-
1975
- 1975-05-13 ZA ZA00753086A patent/ZA753086B/en unknown
- 1975-05-13 NZ NZ177508A patent/NZ177508A/en unknown
- 1975-05-14 IL IL47299A patent/IL47299A/en unknown
- 1975-06-06 AU AU81912/75A patent/AU498387B2/en not_active Expired
- 1975-06-16 SE SE7506908A patent/SE431755B/en not_active IP Right Cessation
- 1975-06-17 BR BR4864/75D patent/BR7503782A/en unknown
- 1975-06-17 DK DK271975A patent/DK153155C/en not_active IP Right Cessation
- 1975-06-17 PH PH17273A patent/PH13030A/en unknown
- 1975-06-18 IE IE1366/75A patent/IE41888B1/en unknown
- 1975-06-18 SU SU752145554A patent/SU635873A3/en active
- 1975-06-18 JP JP50074251A patent/JPS625917B2/ja not_active Expired
- 1975-06-18 FI FI751815A patent/FI751815A7/fi not_active Application Discontinuation
- 1975-06-19 LU LU72771A patent/LU72771A1/xx unknown
- 1975-06-19 DE DE19752527291 patent/DE2527291A1/en active Granted
- 1975-06-19 FR FR7519213A patent/FR2275215A1/en active Granted
- 1975-06-20 CA CA229,803A patent/CA1111021A/en not_active Expired
- 1975-06-20 HU HUHO1808A patent/HU170576B/hu unknown
- 1975-06-20 GB GB2634175A patent/GB1471804A/en not_active Expired
- 1975-06-20 NL NLAANVRAGE7507390,A patent/NL180665C/en not_active IP Right Cessation
- 1975-06-20 CU CU7534293A patent/CU34293A/en unknown
- 1975-06-20 AT AT476975A patent/AT337897B/en not_active IP Right Cessation
- 1975-06-20 NO NO752202A patent/NO752202L/no unknown
- 1975-06-20 DD DD186797A patent/DD121113A5/xx unknown
- 1975-06-20 BE BE157517A patent/BE830455A/en not_active IP Right Cessation
-
1976
- 1976-01-07 SU SU762309104A patent/SU589921A3/en active
-
1987
- 1987-08-28 DK DK453687A patent/DK155329C/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA751806B (en) | Pharmaceutical compositions | |
| ZA74385B (en) | Pharmaceutical compositions | |
| IL48637A0 (en) | 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted omega-pentanorprostaglandins and pharmaceutical compositions containing them | |
| IL47360A0 (en) | Cephalosporins,their preparation and pharmaceutical compositions containing them | |
| ZA755998B (en) | Pharmaceutical compositions | |
| IL46390A0 (en) | New cephalosporin derivative,its preparation and pharmaceutical compositions containing it | |
| IL47329A (en) | Pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them | |
| IL46965A (en) | Pharmaceutical composition containing heparinoidic factor | |
| IL46631A0 (en) | New cephalosporins,their preparation and pharmaceutical compositions containing them | |
| IL47299A0 (en) | Cephalosporin compounds their preparation and pharmaceutical compositions containing them | |
| IL47826A (en) | 7-aminoalkoxy-chroman and-tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them | |
| IL47892A (en) | Cinnamamide derivatives their preparation and pharmaceutical compositions containing them | |
| MY8100372A (en) | Pharmaceutical compositions | |
| NZ179598A (en) | Cephalosporins and pharmaceutical compositions | |
| IL48617A0 (en) | 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them | |
| IL48183A0 (en) | New cephalosporin derivatives,processes for their preparation and pharmaceutical compositions containing them | |
| IL48441A (en) | Isoindole derivatives their manufacture and pharmaceutical compositions containing them | |
| IL50945A0 (en) | Novel cephalosporins their preparation and pharmaceutical compositions containing them | |
| IL48098A0 (en) | Pharmaceutical compositions containing diphenylethanol derivatives | |
| ZA755802B (en) | Pharmaceutical compositions | |
| IL46194A0 (en) | Dibenzoxepin compounds,their preparation and pharmaceutical compositions containing them | |
| HK73178A (en) | Pharmaceutical compositions | |
| PH12855A (en) | Pharmaceutical compositions | |
| IL48309A (en) | 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions containing them | |
| PH11824A (en) | Benzo-naphthyridines and pharmaceutical compositions containing same |